Tools

LEADER 02147nam 2200493 i 4500

001 on1259439473;

003 OCoLC;

005 20210708095034.0;

006 m o d f ;

007 cr |||||||||||;

008 210708s2010 dcua ob f000 0 eng c;

035 a| (Sirsi) o1259439473;

042 a| pcc;

043 a| a-cc---a| n-us---;

049 a| ERE#;

074 a| 1089-A-11 (online);

086 0 a| Y 3.2:C 44/P 84;

245 00 a| Potential health & safety impacts from pharmaceuticals and supplements containing Chinese-sourced raw ingredients.;

246 3 a| Potential health and safety impacts from pharmaceuticals and supplements containing Chinese-sourced raw ingredients;

264 1 a| [Washington, D.C.] :b| U.S.-China Economic and Security Review Commission,c| 2010.;

300 a| 1 online resource (ii, 65 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "Prepared for U.S. China Economic and Security Review Commission.";

500 a| "NSD Bio Group, LLC.";

500 a| "April 2010.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

588 a| Description based on online resource, PDF version; title from cover (USSC, viewed Jul. 7, 2021).;

650 0 a| Raw materialsz| China.=| ^A45949;

650 0 a| Drugsx| Standardsz| United States.=| ^A1001117;

650 0 a| Dietary supplementsx| Standardsz| United States.=| ^A12221;

650 0 a| Pharmaceutical industryz| United Statesx| Quality control.=| ^A638;

650 0 a| Drug factoriesz| Chinax| Quality control.=| ^A854113;

710 2 a| U.S.-China Economic and Security Review Commissione| issuing body.=| ^A574106;

856 40 u| https://purl.fdlp.gov/GPO/gpo157402;

922 a| BIBCONEWb| 20210708;

922 a| UNREPORTEDPUBSASKGPOb| 20210708;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5663396;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5663396-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 8/18/2021x| EDOCUMENTz| JERESOURCE;

Potential health & safety impacts from pharmaceuticals and supplements containing Chinese-sourced raw ingredients.

Other author	U.S.-China Economic and Security Review Commission issuing body.
Format	Electronic
Publication	[Washington, D.C.] : U.S.-China Economic and Security Review Commission, 2010.
Description	1 online resource (ii, 65 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo157402
Subjects	Raw materials--China. Drugs--Standards. --United States. Dietary supplements--Standards. --United States. Pharmaceutical industry--United States. --Quality control. Drug factories--China. --Quality control.

Variant title	Potential health and safety impacts from pharmaceuticals and supplements containing Chinese-sourced raw ingredients
General note	"Prepared for U.S. China Economic and Security Review Commission."
General note	"NSD Bio Group, LLC."
General note	"April 2010."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource, PDF version; title from cover (USSC, viewed Jul. 7, 2021).
GPO item number	1089-A-11 (online)
Govt. docs number	Y 3.2:C 44/P 84

Click here for more information about this title